Follow
Paola Neri
Paola Neri
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells
E Carbone, P Neri, M Mesuraca, MT Fulciniti, T Otsuki, D Pende, V Groh, ...
Blood 105 (1), 251-258, 2005
4162005
Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells
L Catley, E Weisberg, T Kiziltepe, YT Tai, T Hideshima, P Neri, P Tassone, ...
Blood 108 (10), 3441-3449, 2006
4012006
Dysfunctional T regulatory cells in multiple myeloma
RH Prabhala, P Neri, JE Bae, P Tassone, MA Shammas, CK Allam, ...
Blood 107 (1), 301-304, 2006
2892006
Role of B-cell–activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment
YT Tai, XF Li, I Breitkreutz, W Song, P Neri, L Catley, K Podar, ...
Cancer research 66 (13), 6675-6682, 2006
2802006
A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells
D Chauhan, G Li, K Podar, T Hideshima, P Neri, D He, N Mitsiades, ...
Cancer research 65 (18), 8350-8358, 2005
2112005
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications
MA Shammas, P Neri, H Koley, RB Batchu, RC Bertheau, V Munshi, ...
Blood 108 (8), 2804-2810, 2006
2002006
Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM)
D Chauhan, P Neri, M Velankar, K Podar, T Hideshima, M Fulciniti, ...
Blood 109 (3), 1220-1227, 2007
1842007
Cytotoxic activity of the maytansinoid immunoconjugate B-B4–DM1 against CD138+ multiple myeloma cells
P Tassone, VS Goldmacher, P Neri, A Gozzini, MA Shammas, ...
Blood 104 (12), 3688-3696, 2004
1812004
Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion
P Neri, L Ren, AK Azab, M Brentnall, K Gratton, AC Klimowicz, C Lin, ...
Blood, The Journal of the American Society of Hematology 117 (23), 6202-6213, 2011
1682011
A clinically relevant SCID-hu in vivo model of human multiple myeloma
P Tassone, P Neri, DR Carrasco, R Burger, VS Goldmacher, R Fram, ...
Blood 106 (2), 713-716, 2005
1632005
MLN120B, a Novel IκB Kinase β Inhibitor, Blocks Multiple Myeloma Cell Growth In vitro and In vivo
T Hideshima, P Neri, P Tassone, H Yasui, K Ishitsuka, N Raje, D Chauhan, ...
Clinical cancer research 12 (19), 5887-5894, 2006
1592006
Neutralizing B-cell–activating factor antibody improves survival and inhibits osteoclastogenesis in a severe combined immunodeficient human multiple myeloma model
P Neri, S Kumar, MT Fulciniti, S Vallet, S Chhetri, S Mukherjee, YT Tai, ...
Clinical Cancer Research 13 (19), 5903-5909, 2007
1582007
Bortezomib-induced “BRCAness” sensitizes multiple myeloma cells to PARP inhibitors
P Neri, L Ren, K Gratton, E Stebner, J Johnson, A Klimowicz, P Duggan, ...
Blood, The Journal of the American Society of Hematology 118 (24), 6368-6379, 2011
1552011
Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma
NJ Bahlis, H Sutherland, D White, M Sebag, S Lentzsch, R Kotb, ...
Blood, The Journal of the American Society of Hematology 132 (24), 2546-2554, 2018
1502018
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
BG Barwick, P Neri, NJ Bahlis, AK Nooka, MV Dhodapkar, DL Jaye, ...
Nature communications 10 (1), 1911, 2019
1362019
Validation of PDGFRβ and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib
AML Coluccia, T Cirulli, P Neri, D Mangieri, MC Colanardi, A Gnoni, ...
Blood, The Journal of the American Society of Hematology 112 (4), 1346-1356, 2008
1272008
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells
T Calimeri, E Battista, F Conforti, P Neri, MT Di Martino, M Rossi, ...
Leukemia 25 (4), 707-711, 2011
1262011
Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo
MA Shammas, H Koley, RC Bertheau, P Neri, M Fulciniti, P Tassone, ...
Leukemia 22 (7), 1410-1418, 2008
1252008
Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo
P Tassone, MT Di Martino, M Ventura, A Pietragalla, I Cucinotto, ...
Cancer biology & therapy 8 (7), 648-653, 2009
1222009
Combination Therapy with Interleukin-6 Receptor Superantagonist Sant7 and Dexamethasone Induces Antitumor Effects in a Novel SCID-hu In vivo Model of …
P Tassone, P Neri, R Burger, R Savino, M Shammas, L Catley, K Podar, ...
Clinical cancer research 11 (11), 4251-4258, 2005
1092005
The system can't perform the operation now. Try again later.
Articles 1–20